Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq
Insider Sale
+$243,360
-5.51%
Shares
Shares Volume: 21,125 Shares
Average Share Price: $11.52
INSIDER
Dube Eric M
CHIEF EXECUTIVE OFFICER (Director)
reported on Sep 9 2024
traded on Sep 5 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 361,975 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $160,087.83 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 20 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $42,449.49 |
| COMPANY PREVIOUS TRADES |